Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

580
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
580

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Outcomes of Radiation After Chemoimmunotherapy for Stage III Lung Cancer.

Clinical lung cancer·2026
Same author

Biomarkers Associated With Extranodal Extension (ENE) in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Systematic Review.

Head & neck·2026
Same author

Updated Review: Using the National Cancer Database for Outcomes-Based Research.

Journal of the American College of Surgeons·2026
Same author

Use of Complementary and Alternative Medicine in the Management of Breast Cancer.

JAMA network open·2026
Same author

Surgical Trainee Familiarity and Knowledge of the Commission on Cancer Operative Standards: A National Survey Study.

Journal of the American College of Surgeons·2026
Same author

Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker-driven therapeutics.

CA: a cancer journal for clinicians·2026
Same journal

Context-Driven Management of Bilateral Diaphragmatic Failure After Phrenic Nerve Sacrifice.

The Annals of thoracic surgery·2026
Same journal

Uncomplicated type B aortic dissection: Are US-based societal guidelines delaying science?

The Annals of thoracic surgery·2026
Same journal

Methodological Paradigms and Clinical Realities in Defining High-Volume Centres for Valve-Sparing Aortic Root Replacement.

The Annals of thoracic surgery·2026
Same journal

Long-Term Outcomes of Concomitant Atrial Fibrillation Management During CABG: Standardization or Compromise?

The Annals of thoracic surgery·2026
Same journal

Ongoing Dialogue and Support for the Future of Congenital Cardiac Surgery.

The Annals of thoracic surgery·2026
Same journal

A Bridge With Gaps.

The Annals of thoracic surgery·2026
See all related articles

Related Experiment Video

Updated: Dec 21, 2025

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

30.4K

Pandemic Recovery Using a COVID-Minimal Cancer Surgery Pathway.

Daniel J Boffa1, Benjamin L Judson2, Kevin G Billingsley2

  • 1Smilow Cancer Hospital, Yale New Haven Hospital, New Haven, Connecticut; Department of Surgery, Yale School of Medicine, New Haven, Connecticut; Department of Neurosurgery, Yale New Haven Hospital, New Haven, Connecticut.

The Annals of Thoracic Surgery
|May 18, 2020
PubMed
Summary
This summary is machine-generated.

Hospitals can minimize COVID-19 transmission risks for surgical patients by implementing a dedicated COVID-minimal surgery pathway. This approach streamlines patient flow and resource allocation to protect vulnerable populations during the pandemic.

More Related Videos

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

650

Related Experiment Videos

Last Updated: Dec 21, 2025

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

30.4K
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

650

Area of Science:

  • Healthcare Management
  • Infectious Disease Control
  • Surgical Oncology

Background:

  • The COVID-19 pandemic significantly disrupted healthcare, leading to the curtailment of elective surgeries to prevent hospital-acquired infections.
  • Resuming elective surgeries requires managing risks for both COVID-19 and non-COVID-19 patients within healthcare settings.

Purpose of the Study:

  • To describe the development and implementation of a COVID-minimal surgery pathway for cancer patients.
  • To outline a strategy for academic medical centers to rapidly establish protocols for safe surgical care during the pandemic.

Main Methods:

  • A predetermined patient flow pathway was designed to minimize exposure risk for surgical patients.
  • The pathway dictated specific locations, personnel, and materials interacting with the cancer surgery population.
  • Implementation was achieved within 7 days at a large academic medical center.

Main Results:

  • A structured COVID-minimal surgery pathway was successfully created and implemented.
  • The pathway aimed to reduce the risk of viral transmission within the hospital environment.

Conclusions:

  • The COVID-minimal surgery pathway provides a framework for safely increasing surgical activity during the ongoing pandemic.
  • Sharing this model can assist other institutions in developing similar protocols to protect patients and align resources effectively.